evolcSign in

Contipro

Czech biotech producing hyaluronic acid and its derivatives for pharma, cosmetics, supplements and veterinary markets

Dolní Dobrouč, CzechiaFounded 1994contipro.com

Highlights

  • Hiring5 open roles
  • New on EvolcAdded 2026-10-19

About Contipro

Contipro researches, develops and manufactures hyaluronic acid (hyaluronan) and its derivatives. According to its website, it obtains the acid by fermentation of Streptococcus zooepidemicus followed by purification, and offers it as powder or in other forms, along with active substances, cosmetic ingredients, medical and veterinary products, and dietary supplements such as Geloren gummies.

The website describes its customers as companies in the pharmaceutical, medical, cosmetic, veterinary and dietary supplement sectors, with sales to more than 80 countries. The company reports ISO 9001:2015, ISO 13485:2016 and GMP and GLP approvals from SÚKL and ÚSKVBL, and it describes its business as product sales of hyaluronan-based materials and products.

The registry lists the company as founded on 30 December 1994 and based in Dolní Dobrouč, Czech Republic. The website dates its origins to 1990 and states that it has more than 250 employees, a site area of 60,000 m2 and nearly 40% of staff in R&D. Open positions listed include HR business partner, data analyst, economist, business development manager and foreign trade manager for Geloren.

Product: Hyaluronic acid powder and other forms, active substances, cosmetic and pharmaceutical ingredients, veterinary and medical products, and dietary supplements.

Open jobs (5)

Leadership

  • Vladimír Velebný · současný generální ředitel

Tech stack

  • Complianz
  • WordPress